MedTrace Logo

The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes

NCT01950806 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2017-04-25

No results posted yet for this study

Summary

The objective of this randomized, controlled feeding study is to investigate the potential health benefits of a pecan-containing diet. The investigators hypothesize the chronic consumption of pecans will improve an array of biomarkers related to cardiovascular disease and type 2 diabetes risk, including indices of oxidative stress, antioxidant activity, inflammation, endothelial function, and insulin resistance when compared with a control diet that is absent nuts.

Conditions

  • Cardiovascular Disease Risk
  • Type 2 Diabetes Risk

Interventions

OTHER

Pecan-containing diet

OTHER

Nut-free diet

Sponsors & Collaborators

  • National Pecan Shellers Association

    collaborator UNKNOWN

  • Tufts University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-08-31
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01950806 on ClinicalTrials.gov